A case of Gitelman syndrome with homozygous SLC12A3 deletion presenting with epilepsy

[11] Mukhtar M(2016)Genotype/phenotype analysis in 67 Chinese patients with Gitelman's syndrome Am J Nephrol 44 159-584

[12] Ahmed A(2016)Genetic features of Chinese patients with Gitelman syndrome: sixteen novel SLC12A3 mutations identified in a new cohort Am J Nephrol 44 113-17

[13] Ullah W(2017)Genetic causes of hypomagnesemia, a clinical overview Pediatr Nephrol 32 1123-195

[14] Saeed R(2002)Electrocardiogram with prolonged QT interval in Gitelman disease Kidney Int 62 580-1082

[15] Hamid M(1976)Hypokalemia: causes, consequences and correction Am J Med Sci 272 5-475

[16] Makino S(2022)Hypocalcemia-induced QT interval prolongation Cardiology 147 191-634

[17] Tajima T(2006)Hypokalemic paralysis due to Gitelman syndrome: a family study Neurology 67 1080-undefined

[18] Shinozuka J(2017)Increased urinary prostaglandin E2 metabolite: a potential therapeutic target of Gitelman syndrome PLoS One 12 e0180811-undefined

[19] Ikumi A(2015)Indomethacin, amiloride, or eplerenone for treating hypokalemia in Gitelman syndrome J Am Soc Nephrol 26 468-undefined

[20] Awaguni H(2013)The adverse effects profile of levetiracetam in epilepsy: a more detailed look Int J Neurosci 124 627-undefined

[11] Mukhtar M(2016)Genotype/phenotype analysis in 67 Chinese patients with Gitelman's syndrome Am J Nephrol 44 159-584

[12] Ahmed A(2016)Genetic features of Chinese patients with Gitelman syndrome: sixteen novel SLC12A3 mutations identified in a new cohort Am J Nephrol 44 113-17

[13] Ullah W(2017)Genetic causes of hypomagnesemia, a clinical overview Pediatr Nephrol 32 1123-195

[14] Saeed R(2002)Electrocardiogram with prolonged QT interval in Gitelman disease Kidney Int 62 580-1082

[15] Hamid M(1976)Hypokalemia: causes, consequences and correction Am J Med Sci 272 5-475

[16] Makino S(2022)Hypocalcemia-induced QT interval prolongation Cardiology 147 191-634

[17] Tajima T(2006)Hypokalemic paralysis due to Gitelman syndrome: a family study Neurology 67 1080-undefined

[18] Shinozuka J(2017)Increased urinary prostaglandin E2 metabolite: a potential therapeutic target of Gitelman syndrome PLoS One 12 e0180811-undefined

[19] Ikumi A(2015)Indomethacin, amiloride, or eplerenone for treating hypokalemia in Gitelman syndrome J Am Soc Nephrol 26 468-undefined

[20] Awaguni H(2013)The adverse effects profile of levetiracetam in epilepsy: a more detailed look Int J Neurosci 124 627-undefined